$NAPD regimen for patients with recurrent refractory diffuse large B-cell lymphoma$

NAPD regimen for patients with recurrent refractory diffuse large B-cell lymphoma

To investigate the clinical efficacy and toxicities for the NAPD regimen (vinorelbine, cytarabine, cisplatin, and dexamethasone) in the treatment of recurrent refractory diffuse large B-cell lymphoma.  Methods: A total of 30 patients identified with recurrent refractory diffuse large B-cell lymphoma...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Zhong nan da xue xue bao. Journal of Central South University. Yi xue ban 2018-07, Vol.43 (7), p.754-759
Hauptverfasser:	Huang, Chenghui, Wu, Hui, Zhu, Haihua, Liu, Lan, Tian, Ruifang, Xu, Cong, Li, Xiaofei, Wang, Lihui, Cao, Ke, Cao, Peiguo
Format:	Artikel
Sprache:	chi
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cisplatin - administration & dosage Cytarabine - administration & dosage Dexamethasone - administration & dosage Humans Induction Chemotherapy Lymphoma, Large B-Cell, Diffuse - drug therapy Lymphoma, Large B-Cell, Diffuse - mortality Neoplasm Recurrence, Local - drug therapy Neoplasm Recurrence, Local - mortality Retrospective Studies Salvage Therapy - methods Treatment Outcome Vinblastine - administration & dosage Vinblastine - analogs & derivatives Vinorelbine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!